SCHEMBL23740537

SCHEMBL23740537

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3cc(-n5c6ccccc6c6c7ccccc7c(-c7ccccc7)cc65)ccc34)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 1/20 0.34
KDM4E B2RXH2 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
MAPK1 P28482 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
ATM Q13315 1/20 0.31
CA12 O43570 1/20 0.31
ALDH2 P05091 1/20 0.31
AKR1B1 P15121 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
HSD17B3 P37058 1/20 0.31
SORD Q00796 1/20 0.31
CA9 Q16790 1/20 0.31
HSD17B10 Q99714 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24118923 0.99 PTGER4 (0.34) PTGER4KDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL24118902 0.95 KDM4E (0.34) PTGER4KDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL21863124 0.95 PTGER4 (0.33) PTGER4KDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL24118911 0.94 PTGER4 (0.36) PTGER4KDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL23740392 0.94 KDM4E (0.34) PTGER4KDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL21862824 0.94 KDM4E (0.33) PTGER4KDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL23740505 0.93 PTGER4 (0.33) PTGER4KDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL23740396 0.93 PTGER4 (0.33) PTGER4KDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL24738798 0.90 KDM4E (0.30) KDM4EL3MBTL1ALDH1A1MAPTHPGD
SCHEMBL23740645 0.89 PTGER4 (0.32) PTGER4KDM4EL3MBTL1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210395263-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE LT MATERIALS CO., LTD. (KR) 2021-12-23 US disclosed
EP-3862353-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE LT Materials Co., Ltd. (KR) 2021-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395263-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE ODC1, AOX1, CYP1B1 PTGER4 1460/4885KDM4E 2786/4885L3MBTL1 1479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.